✦ LIBER ✦

Clinical Significance of Heterogeneity in Response to Retreatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Lung Cancer Acquiring Secondary Resistance to the Drug

✍ Scribed by Lee, Youngjoo; Kim, Hyae Young; Lee, Soo-Hyun; Lim, Kun Young; Lee, Geon Kook; Yun, Tak; Han, Ji-Youn; Kim, Heung Tae; Lee, Jin Soo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of Acquired Resistance to Epi

✍ Engelman, J. A.; Janne, P. A. 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 311 KB

Acquired resistance mechanisms to tyrosi

✍ Suda, Kenichi; Mizuuchi, Hiroshi; Maehara, Yoshihiko; Mitsudomi, Tetsuya 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 398 KB

Management of acquired resistance to epi

✍ Sacher, Adrian G.; Jänne, Pasi A.; Oxnard, Geoffrey R. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

EKB-569, a new irreversible epidermal gr

✍ Yoshimura, Naruo; Kudoh, Shinzoh; Kimura, Tatsuo; Mitsuoka, Shigeki; Matsuura, K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Antitumor activity of bortezomib in huma

✍ Morgillo, Floriana; D’Aiuto, Elena; Troiani, Teresa; Martinelli, Erika; Cascone, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 894 KB

Subsequent brain metastasis responses to

✍ Gounant, Valérie; Wislez, Marie; Poulot, Virginie; Khalil, Antoine; Lavole, Arme 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 355 KB